Transaminases

Known as: Aminotransferases, Aminotransferase, Transaminase 
Transaminases are a sub-subclass of mostly pyridoxal phosphate-dependent transferase enzymes that catalyze the transfer of an amino group from a… (More)
National Institutes of Health

Related topics

Related topics

49 relations

Narrower (37)

4-Aminobutyrate aminotransferase7,8-diaminopelargonic acid aminotransferaseAGD2-LIKE DEFENSE RESPONSE PROTEIN1, ArabidopsisAcetylornithine aminotransferase
(More)
BCAT1 geneEnzyme GeneIn BloodProcess of secretion
(More)

Broader (2)

Nitrogenous Group TransferasesTransferase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Hydrogen sulfide in pharmacology and medicine--An update.
Hydrogen sulfide (H2S) is the endogenously produced gasotransmitter involved in the regulation of nervous system, cardiovascular… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
BACKGROUND In single-group studies, chromosomal rearrangements of the anaplastic lymphoma kinase gene (ALK) have been associated… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase…
BACKGROUND Activating mutations in EGFR are important markers of response to tyrosine kinase inhibitor (TKI) therapy in non-small… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
BACKGROUND Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (EGFR) is highly… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Chronic hepatitis B: update 2009.
The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Management of Chronic… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
Liver stiffness was measured by transient elastography (FibroScan) in 228 consecutive patients with chronic viral hepatitis, with… (More)
  • table 1
  • figure 1
  • table 4
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
CONTEXT Serum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy of antiviral treatment in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
BACKGROUND Previous trials have demonstrated that lowering low-density lipoprotein (LDL) cholesterol levels below currently… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), its pathogenesis and clinical significance remain… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC) patients. However, most models for… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?